00000nas 2200000za 4500 9.506080 CaOODSP 20251204081319 cr ||||||||||| 150406c19969999oncar p o f0 a0eng|d 1495-0561 CaOODSP eng n-cn--- H78E-PDF Canada. Patented Medicine Prices Review Board. Annu. rep. - Can., Pat. Med. Prices Rev. Board (Online) Annual report - Canada. Patented Medicine Prices Review Board (Online) Annual report [electronic resource] / Patented Medicine Prices Review Board. PMPRB annual report [Ottawa] : Patented Medicine Prices Review Board, [199-]- Annual 9th (1996)- Issued also in French under title: Rapport annuel / Conseil d'examen du prix des médicaments brevetés. An independent, quasi-judicial body, Canada’s Patented Medicine Prices Review Board (PMPRB) regulates the prices of prescription and non-prescription patented drugs for human and veterinary use, ensuring that these prices are not excessive. This report includes a review of the PMPRB’s major activities, as well as analyses of the prices of patented medicines and of the price trends of all drugs. It also lists the R&D expenditures reported by patent-holding drug manufacturers. gccst Drugs gccst Patents Rapport annuel (CaOODSP)9.502482 Patented Medicine Prices Review Board annual report (CaOODSP)9.512094